Q96AD5 (PLPL2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 86.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Patatin-like phospholipase domain-containing protein 2 EC=3.1.1.3 Alternative name(s): Adipose triglyceride lipase Calcium-independent phospholipase A2 Desnutrin IPLA2-zeta Pigment epithelium-derived factor TTS2.2 Transport-secretion protein 2 Short name=TTS2 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 504 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Catalyzes the initial step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets. Also has acylglycerol transacylase activity. May act coordinately with LIPE/HLS within the lipolytic cascade. Regulates adiposome size and may be involved in the degradation of adiposomes. May play an important role in energy homeostasis. May play a role in the response of the organism to starvation, enhancing hydrolysis of triglycerides and providing free fatty acids to other tissues to be oxidized in situations of energy depletion. Ref.1 Ref.6 Ref.10 |
| Catalytic activity | Triacylglycerol + H2O = diacylglycerol + a carboxylate. |
| Enzyme regulation | Inhibited by BEL ((E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one), a suicide substrate inhibitor. No differences in enzymatic activity that uses (1,2-dilinoleoyl)-phosphatidylcholine as substrate was detected in the presence or absence of ATP. Activated by ABHD5 and SERPINF1. Ref.6 Ref.11 |
| Pathway | |
| Subunit structure | Interacts with ABHD5; this association stimulates PNPLA2 triglyceride hydrolase activity By similarity. Interacts with SERPINF1; interacts at one site of interaction. Despite a colocalization in lipid droplets, it probably does not interact with PLIN By similarity. Ref.11 |
| Subcellular location | Lipid droplet. Cell membrane; Single-pass type II membrane protein Ref.10 Ref.11. |
| Tissue specificity | Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). Ref.1 Ref.7 Ref.8 Ref.11 |
| Developmental stage | Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium. Ref.7 Ref.9 Ref.11 |
| Post-translational modification | Phosphorylation at Ser-404 by PKA is increased during fasting and moderate intensity exercise, and moderately increases lipolytic activity By similarity. Phosphorylation at Ser-404 is increased upon beta-adrenergic stimulation. |
| Polymorphism | Genetic variations in PNPLA2 may be associated with plasma free fatty acids, triglycerides levels, and fasting glucose concentrations. |
| Involvement in disease | Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2. Neutral lipid storage disease with myopathy (NLSDM) [MIM:610717]: Neutral lipid storage disorder (NLSD) with myopathy but without ichthyosis. NLSDs are characterized by the presence of triglyceride-containing cytoplasmic droplets in leukocytes and in other tissues, including bone marrow, skin, and muscle. Individuals with NLSDM did not show obesity, in spite of a defect in triglyceride degradation in fibroblasts and in marked triglyceride storage in liver, muscles, and other visceral cells. |
| Sequence similarities | Contains 1 patatin domain. |
| Biophysicochemical properties | pH dependence: Optimum pH is 7.5 with (1,2-dilinoleoyl)-phosphatidylcholine as substrate. Ref.11 |
| Sequence caution | The sequence AAP34448.1 differs from that shown. Reason: Frameshift at position 501. The sequence CAC01131.1 differs from that shown. Reason: Erroneous initiation. The sequence CAC01132.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96AD5-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96AD5-2) The sequence of this isoform differs from the canonical sequence as follows: 1-324: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 504 | 504 | Patatin-like phospholipase domain-containing protein 2 | PRO_0000292527 | |||||
Regions | |||||||||
| Topological domain | 1 – 8 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 9 – 29 | 21 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||
| Topological domain | 30 – 504 | 475 | Lumenal Potential | ||||||
| Domain | 10 – 179 | 170 | Patatin | ||||||
| Motif | 45 – 49 | 5 | GXSXG | ||||||
Sites | |||||||||
| Active site | 47 | 1 | |||||||
Amino acid modifications | |||||||||
| Modified residue | 372 | 1 | Phosphoserine; in vitro By similarity | ||||||
| Modified residue | 404 | 1 | Phosphoserine; by PKA Ref.14 | ||||||
| Modified residue | 428 | 1 | Phosphoserine Ref.13 | ||||||
| Glycosylation | 39 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 324 | 324 | Missing in isoform 2. | VSP_026421 | |||||
| Natural variant | 195 | 1 | P → L in NLSDM. Ref.16 | VAR_032995 | |||||
| Natural variant | 219 | 1 | L → F. Ref.15 | VAR_032996 | |||||
| Natural variant | 252 | 1 | N → K. Ref.15 | VAR_032997 | |||||
| Natural variant | 481 | 1 | L → P. Ref.2 Ref.4 Ref.15 Corresponds to variant rs1138693 [ dbSNP | Ensembl ]. | VAR_032998 | |||||
Experimental info | |||||||||
| Mutagenesis | 47 | 1 | S → A: Reduces rate of lipid hydrolysis; does not affect the localization around the rim of the adiposomes. Ref.8 Ref.10 | ||||||
| Sequence conflict | 163 | 1 | R → G in AAC09354. Ref.5 | ||||||
| Sequence conflict | 296 | 1 | I → V in AAW81962. Ref.1 | ||||||
| Sequence conflict | 333 | 1 | A → G in AAP34448. Ref.3 | ||||||
| Sequence conflict | 351 | 1 | R → C in AAW81962. Ref.1 | ||||||
| Sequence conflict | 402 | 1 | V → L in CAC01131. Ref.2 | ||||||
| Sequence conflict | 402 | 1 | V → L in CAC01132. Ref.2 | ||||||
| Sequence conflict | 419 | 1 | L → P in AAW81962. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase." Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R. Science 306:1383-1386(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY. |
| [2] | "TTS-2, a novel protein implicated in vesicular transport of the cell surface receptor ICAM-3." Strahl T., Shingler W.H., Lammiman M., Gregory C.D., Leach L., Matthias P., Nielsen P.J., Shaw P.E. Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT PRO-481. |
| [3] | "Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. Gu J.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT PRO-481. Tissue: Brain and Eye. |
| [5] | Yu W., Gibbs R.A. Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 94-504 (ISOFORM 1). Tissue: Brain. |
| [6] | "Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities." Jenkins C.M., Mancuso D.J., Yan W., Sims H.F., Gibson B., Gross R.W. J. Biol. Chem. 279:48968-48975(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION. |
| [7] | "Adipocyte lipases and defect of lipolysis in human obesity." Langin D., Dicker A., Tavernier G., Hoffstedt J., Mairal A., Ryden M., Arner E., Sicard A., Jenkins C.M., Viguerie N., van Harmelen V., Gross R.W., Holm C., Arner P. Diabetes 54:3190-3197(2005) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE, TISSUE SPECIFICITY. |
| [8] | "Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members." Lake A.C., Sun Y., Li J.-L., Kim J.E., Johnson J.W., Li D., Revett T., Shih H.H., Liu W., Paulsen J.E., Gimeno R.E. J. Lipid Res. 46:2477-2487(2005) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, MUTAGENESIS OF SER-47. |
| [9] | "The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma." Kim J.Y., Tillison K., Lee J.-H., Rearick D.A., Smas C.M. Am. J. Physiol. 291:E115-E127(2006) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE. |
| [10] | "ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells." Smirnova E., Goldberg E.B., Makarova K.S., Lin L., Brown W.J., Jackson C.L. EMBO Rep. 7:106-113(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-47. |
| [11] | "Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor." Notari L., Baladron V., Aroca-Aguilar J.D., Balko N., Heredia R., Meyer C., Notario P.M., Saravanamuthu S., Nueda M.-L., Sanchez-Sanchez F., Escribano J., Laborda J., Becerra S.P. J. Biol. Chem. 281:38022-38037(2006) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION WITH SERPINF1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [13] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY. |
| [14] | "Identification and functional characterization of protein kinase A phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase." Pagnon J., Matzaris M., Stark R., Meex R.C., Macaulay S.L., Brown W., O'Brien P.E., Tiganis T., Watt M.J. Endocrinology 153:4278-4289(2012) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-404. |
| [15] | "The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes." Schoenborn V., Heid I.M., Vollmert C., Lingenhel A., Adams T.D., Hopkins P.N., Illig T., Zimmermann R., Zechner R., Hunt S.C., Kronenberg F. Diabetes 55:1270-1275(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PHE-219; LYS-252 AND PRO-481, POLYMORPHISM, ASSOCIATION WITH DIABETES MELLITUS TYPE 2. |
| [16] | "The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy." Fischer J., Lefevre C., Morava E., Mussini J.-M., Laforet P., Negre-Salvayre A., Lathrop M., Salvayre R. Nat. Genet. 39:28-30(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT NLSDM LEU-195. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY894804 mRNA. Translation: AAW81962.1. AJ278475 mRNA. Translation: CAC01131.1. Different initiation. AJ278476 mRNA. Translation: CAC01132.1. Different initiation. AY203925 mRNA. Translation: AAP34448.1. Frameshift. BC011958 mRNA. Translation: AAH11958.1. BC017280 mRNA. Translation: AAH17280.1. AF055000 mRNA. Translation: AAC09354.1. |
| IPI | IPI00550361. IPI00847143. |
| RefSeq | NP_065109.1. NM_020376.3. |
| UniGene | Hs.654697. |
3D structure databases | |
| ProteinModelPortal | Q96AD5. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q96AD5. 4 interactions. |
| MINT | MINT-1184430. |
| STRING | 9606.ENSP00000337701. |
PTM databases | |
| PhosphoSite | Q96AD5. |
Polymorphism databases | |
| DMDM | 74731110. |
Proteomic databases | |
| PaxDb | Q96AD5. |
| PRIDE | Q96AD5. |
Protocols and materials databases | |
| DNASU | 57104. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000336615; ENSP00000337701; ENSG00000177666. |
| GeneID | 57104. |
| KEGG | hsa:57104. |
| UCSC | uc001lrt.3. human. |
Organism-specific databases | |
| CTD | 57104. |
| GeneCards | GC11P000808. |
| HGNC | HGNC:30802. PNPLA2. |
| MIM | 609059. gene. 610717. phenotype. |
| neXtProt | NX_Q96AD5. |
| Orphanet | 98908. Neutral lipid storage myopathy. |
| PharmGKB | PA134903083. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG261571. |
| HOVERGEN | HBG007046. |
| InParanoid | Q96AD5. |
| KO | K16816. |
| OMA | LVLREMC. |
| OrthoDB | EOG498V0W. |
| PhylomeDB | Q96AD5. |
Enzyme and pathway databases | |
| Reactome | REACT_111217. Metabolism. |
| UniPathway | UPA00256. |
Gene expression databases | |
| Bgee | Q96AD5. |
| CleanEx | HS_PNPLA2. |
| Genevestigator | Q96AD5. |
Family and domain databases | |
| InterPro | IPR016035. Acyl_Trfase/lysoPLipase. IPR002641. Patatin/PLipase_A2-rel. [Graphical view] |
| Pfam | PF01734. Patatin. 1 hit. [Graphical view] |
| SUPFAM | SSF52151. Acyl_Trfase/lysoPlipase. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | PNPLA2. human. |
| GenomeRNAi | 57104. |
| NextBio | 62941. |
| SOURCE | Search... |
Entry information
| Entry name | PLPL2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96AD5 Secondary accession number(s): O60643 Q9NQ62 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
